Optional: Social Subscribe/Login
- European Network of Paediatric Research at EMA elects new chair, , 14/10/2019 October 14, 2019
- Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 8-10 October 2019, CVMP, 11/10/2019 October 11, 2019
- EMA Management Board: highlights of October 2019 meeting, , 04/10/2019 October 4, 2019
- Four-week limit for use of high-strength estradiol creams , PRAC, 04/10/2019 October 4, 2019
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2019, PRAC, 04/10/2019 October 4, 2019
- Arzneimittelstudien für neue, gezielte Therapieansätze: 300 Experten beraten in Bonn Chancen und Herausforderungen komplexer klinischer Studien.
- Fälschung des Arzneimittels Sovaldi® 400 mg Filmtabletten (Charge VVDXD) auf den deutschen Markt gelangt
- G-BA, BfArM und PEI intensivieren Zusammenarbeit: Leitfaden zu gemeinsamen Beratungsgesprächen mit pharmazeutischen Unternehmen veröffentlicht
- Fälschung des Arzneimittels Harvoni® 90 mg / 400 mg Filmtabletten (Charge 16SFC021D) auf den deutschen Markt gelangt (mit Ergänzungen vom 22.06., 14.06. und 06.06.2017)
- BfArM erweitert Informationsangebot im Zusammenhang mit Lieferengpässen
- Adaptation of the Guidance document Packaging texts for veterinary medicinal products HMV4 October 10, 2019
- Batch recall – Eloxatine, Infusionskonzentrat October 8, 2019
- Batch recall – Oxaliplatin Zentiva, Infusionskonzentrat October 8, 2019
- Anpassung der Praxis bezüglich Arzneimittelinformation October 8, 2019
- Adverse events following immunization – annual Vaccinovigilance report October 4, 2019
- Warnung: Wilke Waldecker Fleisch- und Wurstwaren - alle Produkte October 2, 2019
- Rückruf: IKEA MATVRÅ Lätzchen in Blau/Rot, 2 St. September 30, 2019
- Rückruf: SIMPEX Hochleistungs-Kleinkompressor 12V September 19, 2019
- Rückruf: Stirnlampe OnNight 410 September 17, 2019
- Rückruf: iglo Süßkartoffel Laibchen 270g September 16, 2019
- In-office gene therapy for wet age-related macular degeneration is coming October 11, 2019Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration (AMD) have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks. Researchers […]
- Powerful new genomics method can be used to reveal the causes of rare genetic diseases October 11, 2019A team led by a scientist at Scripps Research has invented a new genomics technique for tracking down the causes of rare genetic diseases.
- Jumping genes can cause rare developmental disorders in children October 11, 2019The largest study of its kind into childhood developmental disorders has discovered that jumping genes cause genetic changes in some patients with undiagnosed neurodevelopmental diseases. The research from the Wellcome Sanger Institute and its collaborators in the NHS Regional Genetics services enabled genetic diagnoses for three children with previously undiagnosed rare developmental diseases who were […]
- New customized drug treatment bypasses a single child's unique mutation within a year of diagnosis October 10, 2019An unprecedented case at Boston Children's Hospital shows that it's possible to do something that's never been done before: identify a patient's unique mutation, design a customized drug to bypass it, manufacture and test the drug, and obtain permission from the Food and Drug Administration (FDA) to begin treating the patient—all in less than one […]
- Multigene testing for all breast cancer patients cost-effective October 10, 2019(HealthDay)—Unselected, multigene testing for all patients with breast cancer would be cost-effective in the United Kingdom and the United States, according to a study published online Oct. 3 in JAMA Oncology.
thasso: kürzliche kommentare